Search By Initial

Cas Index 1

• 117928-94-6 | GLYX 13 (Catalog# : 011809)Coming soon!
• 1168091-68-6 | GDC-0623 (Catalog# : 010811)GDC-0623 is a potent, ATP-uncompetitive inhibitors of MEK1(Ki=0.13 nM, +ATP); 6-fold
• 1075236-89-3 | Gepotidacin (Catalog# : 010610)Gepotidacin is a potent Type II DNA topoisomerase inhibitor. Gepotidacin is a novel a
• 1217457-86-7 | GGTI-298 (Catalog# : 010609)GGTI-298 is a potent geranylgeranyltransferase-I (GGTase-I) inhibitor with potential
• 1443461-21-9 | GSK2838232 (Catalog# : 122924)GSK2838232 is a novel human immune virus (HIV) maturation inhibitor being developed f
• 1431368-48-7 | GSK-LSD1 2HCl (Catalog# : 122505)Coming soon!
• 1346704-33-3 | GSK343 (Catalog# : 122402)GSK343 is a potent and selective EZH2 inhibitor with IC50 of 4 nM, showing 60 fold se
• 1032823-75-8 | GSK1292263 (Catalog# : 121430)GSK1292263 is a novel GPR119 receptor agonist used for the treatment of type 2 diabet
• 1089283-49-7 | GSK1904529A (Catalog# : 121428)GSK1904529A is a selective inhibitor of IGF-1R and IR with IC50 of 27 nM and 25 nM, &
• 1229236-86-5 | Gandotinib(LY2784544) (Catalog# : 91415)Gandotinib is an orally bioavailable imidazopyridazine and inhibitor of Janus kinase
• 1365888-06-7 | GDC-0810 ( Brilanestrant , ARN-810 ) (Catalog# : 90731)GDC-0810 (Brilanestrant, ARN-810, RG6046) is a selective estrogen receptor degrader (
• 1380672-07-0 | G007-LK (Catalog# : 62908)G007-LK is specific tankyrase 1/2 inhibitor.G007-LK (66) displayed high selectivity t
• 1207360-89-1 | GDC-0349 (Catalog# : 62702)GDC-0349 is a potent and selective ATP-competitive inhibitor of mTOR.
• 103766-25-2 | Gimeracil (Catalog# : 52804)Gimeracil(Gimestat) is an inhibitor of dihydropyrimidine dehydrogenase (DPYD), which
• 1260907-17-2 | GSK 525762A (Catalog# : 52745)GSK 525762A (I-BET 762) is an inhibitor for BET proteins with IC50 of ~35 nM.
• 1218942-37-0 | GKT137831 (Catalog# : 52627)GKT137831 is a novel and specific dual Nox1/Nox4 inhibitor with Ki of 14040 nM and 11
• 1372540-25-4 | GSK2636771 (Catalog# : 52618)GSK2636771 is a potent, orally bioavailable and selective inhibitor of PI3K (0.89 nM)
• 1047634-63-8 | GSK2110183 (Catalog# : 52584)GSK2110183 is an orally bioavailable, selective, ATP-competitive and potent pan-Akt i
• 1262618-39-2 | GS967 (Catalog# : 52216)GS967 is a novel, potent, and selective inhibitor of cardiac late sodium current(late
• 1346574-57-9 | GSK126 (Catalog# : 52208)GSK126 is a potent, highly selectiveEZH2 methyltransferaseinhibitor withIC50of 9.9 nM
• 1346572-63-1 | GSK503 (Catalog# : 51805)GSK-503 is a potent EZH2 inhibitor with potential anticancer activity. Reference: 1.
• 1394076-92-6 | GNE-317 (Catalog# : 52215)GNE-317 is a potent, brain-penetrantPI3Kinhibitor
• 188591-46-0 | GSK3787 (Catalog# : 52018)GSK3787 is as a selective and irreversible antagonist ofPPARwithpIC50of 6.6, with no
• 1337532-29-2 | GSK 2656157 (Catalog# : 52019)GSK2656157 is an ATP-competitive and highly selective inhibitor ofPERKwithIC50of 0.9
• 1095539-84-6 | 1H-Indazole, 6-bromo-1,3-dimethyl- (Catalog# : 25036)
• 1644645-32-8 | HTL14242 (Catalog# : 24115)HTL14242 is a mGlu5 Negative Allosteric Modulator. Metabotropic glutamate receptors (
• 1441057-15-3 | 2(1H)-Pyridinone, 5,6-dihydro-4-(4-methylphenyl)-3-(2H-tetrazol-5-yl)-6-[4-(4,4,4-trifluorobutoxy)phenyl]-6-(trifluoromethyl)-, (6S)- (Catalog# : 20430)
• 182318-78-1 | 4-hydroxybiphenyl-4-carboxamide (Catalog# : 20404)
• 173933-40-9 | HISPOLON(P) (Catalog# : 210201)
• 1415792-84-5 | HMPL-523 (Catalog# : 20123101)HMPL-523 is a novel, highly selective and potent small molecule oral inhibitor target